FVIII inhibitors consist of a polyclonal population of antibodies. Previous studies have demonstrated different distribution of IgG subclasses. IgG4 was associated to high level of FVIII inhibitors and failure of Immune Tolerance Induction (ITI) treatment. This study monitored the relative distribution of IgG subclasses of anti-FVIII in Severe Hemophilia A (SHA) patients.Fil: Irigoyen, María Belén. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Primiani, L.. Fundacion Argentina de Hemofilia; ArgentinaFil: Felippo, Marta Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto d...
Introduction: Haemophilia A (HA) is an inherited X-chromosome recessive disorder characterized by f...
El desarrollo de inhibidores de FVIII en hemofilia A (HA) es considerado un rasgo complejo, ya que i...
In haemophilia B (HB) (factor IX [FIX] deficiency), F9 genotype largely determines clinical phenotyp...
The development of inhibitory antibodies against factor VIII (FVIII) (inhibitor) is the major compli...
The development of inhibitory antibodies against factor VIII (FVIII) (inhibitor) is the major compli...
The eradication of inhibitory antibodies in patients with haemophilia A can be accomplished by frequ...
Inhibitor development against exogenous factor VIII is a severe impairment of replacement therapy af...
Preventing factor VIII (FVIII) inhibitors following replacement therapies with FVIII products in pat...
Fil: Marchione, Vanina Daniela. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin...
Le facteur VIII (FVIII) joue un rôle essentiel dans la coagulation sanguine. Lorsque le FVIII fait g...
International audienceINTRODUCTION:Approximately, 25% of haemophilia A (HA) patients treated by fact...
Despite the clinical relevance of anti-factor VIII (FVIII) antibodies (anti-FVIII inhibitors) impair...
International audienceWe report the observation of a 75-year-old patient referred for cervical lymph...
Immune tolerance induction (ITI) by prolonged administration of FVIII is currently the only strategy...
Evidence of antibody isotype/subtype switching may provide prognostic value regarding the state of i...
Introduction: Haemophilia A (HA) is an inherited X-chromosome recessive disorder characterized by f...
El desarrollo de inhibidores de FVIII en hemofilia A (HA) es considerado un rasgo complejo, ya que i...
In haemophilia B (HB) (factor IX [FIX] deficiency), F9 genotype largely determines clinical phenotyp...
The development of inhibitory antibodies against factor VIII (FVIII) (inhibitor) is the major compli...
The development of inhibitory antibodies against factor VIII (FVIII) (inhibitor) is the major compli...
The eradication of inhibitory antibodies in patients with haemophilia A can be accomplished by frequ...
Inhibitor development against exogenous factor VIII is a severe impairment of replacement therapy af...
Preventing factor VIII (FVIII) inhibitors following replacement therapies with FVIII products in pat...
Fil: Marchione, Vanina Daniela. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin...
Le facteur VIII (FVIII) joue un rôle essentiel dans la coagulation sanguine. Lorsque le FVIII fait g...
International audienceINTRODUCTION:Approximately, 25% of haemophilia A (HA) patients treated by fact...
Despite the clinical relevance of anti-factor VIII (FVIII) antibodies (anti-FVIII inhibitors) impair...
International audienceWe report the observation of a 75-year-old patient referred for cervical lymph...
Immune tolerance induction (ITI) by prolonged administration of FVIII is currently the only strategy...
Evidence of antibody isotype/subtype switching may provide prognostic value regarding the state of i...
Introduction: Haemophilia A (HA) is an inherited X-chromosome recessive disorder characterized by f...
El desarrollo de inhibidores de FVIII en hemofilia A (HA) es considerado un rasgo complejo, ya que i...
In haemophilia B (HB) (factor IX [FIX] deficiency), F9 genotype largely determines clinical phenotyp...